

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.15649469 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.15649469 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64857595 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.63469845 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.63469845 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.63469845 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.63469845 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.63469845 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.63469845 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.22570301 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04953326 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.02732577 |
| 13 | detection of other organism (GO:0098543) | 3.91240353 |
| 14 | detection of bacterium (GO:0016045) | 3.89765669 |
| 15 | positive thymic T cell selection (GO:0045059) | 3.78949137 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 3.72624578 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 3.67312973 |
| 18 | response to peptidoglycan (GO:0032494) | 3.66359848 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.63824631 |
| 20 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.60663235 |
| 21 | nuclear pore complex assembly (GO:0051292) | 3.56491796 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.53619273 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.52416355 |
| 24 | leukocyte aggregation (GO:0070486) | 3.50115065 |
| 25 | protein localization to kinetochore (GO:0034501) | 3.48507260 |
| 26 | negative T cell selection (GO:0043383) | 3.45226684 |
| 27 | nuclear pore organization (GO:0006999) | 3.40733602 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 3.38220756 |
| 29 | positive regulation of granulocyte differentiation (GO:0030854) | 3.37787172 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.36865500 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.34433533 |
| 32 | DNA unwinding involved in DNA replication (GO:0006268) | 3.31060484 |
| 33 | mitotic nuclear envelope disassembly (GO:0007077) | 3.29004727 |
| 34 | dosage compensation (GO:0007549) | 3.28391095 |
| 35 | response to host immune response (GO:0052572) | 3.24039131 |
| 36 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.24039131 |
| 37 | regulation of necroptotic process (GO:0060544) | 3.21016506 |
| 38 | respiratory burst (GO:0045730) | 3.19439468 |
| 39 | hemoglobin metabolic process (GO:0020027) | 3.19373904 |
| 40 | thymic T cell selection (GO:0045061) | 3.17877202 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.15568760 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 3.15265821 |
| 43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.15027748 |
| 44 | neutrophil activation (GO:0042119) | 3.14967451 |
| 45 | response to interleukin-15 (GO:0070672) | 3.12799040 |
| 46 | cellular extravasation (GO:0045123) | 3.12311979 |
| 47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.11967636 |
| 48 | positive regulation of B cell differentiation (GO:0045579) | 3.10567883 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.09849419 |
| 50 | response to host (GO:0075136) | 3.09849419 |
| 51 | response to host defenses (GO:0052200) | 3.09849419 |
| 52 | IMP biosynthetic process (GO:0006188) | 3.09722212 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.09183953 |
| 54 | protein localization to chromosome, centromeric region (GO:0071459) | 3.08041985 |
| 55 | positive T cell selection (GO:0043368) | 3.06206248 |
| 56 | oxygen transport (GO:0015671) | 3.04858479 |
| 57 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.03976766 |
| 58 | modulation by virus of host process (GO:0019054) | 3.03796203 |
| 59 | regulation of B cell differentiation (GO:0045577) | 3.03318486 |
| 60 | membrane disassembly (GO:0030397) | 3.03190993 |
| 61 | nuclear envelope disassembly (GO:0051081) | 3.03190993 |
| 62 | T cell selection (GO:0045058) | 3.00346251 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 2.97539367 |
| 64 | detection of molecule of bacterial origin (GO:0032490) | 2.97156595 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94883809 |
| 66 | granulocyte activation (GO:0036230) | 2.94423735 |
| 67 | regulation of translational fidelity (GO:0006450) | 2.93655533 |
| 68 | response to muramyl dipeptide (GO:0032495) | 2.92711129 |
| 69 | negative regulation of phagocytosis (GO:0050765) | 2.92001004 |
| 70 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.91169740 |
| 71 | heterochromatin organization (GO:0070828) | 2.89938712 |
| 72 | cellular response to type I interferon (GO:0071357) | 2.88901253 |
| 73 | type I interferon signaling pathway (GO:0060337) | 2.88901253 |
| 74 | nucleobase biosynthetic process (GO:0046112) | 2.88822654 |
| 75 | negative regulation of innate immune response (GO:0045824) | 2.88796072 |
| 76 | microglial cell activation (GO:0001774) | 2.88298202 |
| 77 | cellular response to virus (GO:0098586) | 2.88196621 |
| 78 | response to type I interferon (GO:0034340) | 2.88172905 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 2.87683352 |
| 80 | regulation of platelet aggregation (GO:0090330) | 2.87288502 |
| 81 | mitotic sister chromatid cohesion (GO:0007064) | 2.84794142 |
| 82 | negative regulation of T cell mediated immunity (GO:0002710) | 2.82888266 |
| 83 | pore complex assembly (GO:0046931) | 2.81698515 |
| 84 | cellular response to interleukin-15 (GO:0071350) | 2.81534274 |
| 85 | detection of biotic stimulus (GO:0009595) | 2.81384067 |
| 86 | B cell mediated immunity (GO:0019724) | 2.80541438 |
| 87 | modulation by symbiont of host cellular process (GO:0044068) | 2.79415424 |
| 88 | T cell migration (GO:0072678) | 2.78818460 |
| 89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75742170 |
| 90 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.75696896 |
| 91 | negative regulation of necroptotic process (GO:0060546) | 2.75411462 |
| 92 | tolerance induction (GO:0002507) | 2.74915280 |
| 93 | DNA duplex unwinding (GO:0032508) | 2.74645102 |
| 94 | DNA geometric change (GO:0032392) | 2.74138635 |
| 95 | macrophage activation (GO:0042116) | 2.72349185 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.71247026 |
| 97 | regulation of granulocyte differentiation (GO:0030852) | 2.70716812 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.70418603 |
| 99 | regulation of translational termination (GO:0006449) | 2.69691986 |
| 100 | purine nucleobase biosynthetic process (GO:0009113) | 2.69638336 |
| 101 | neutrophil mediated immunity (GO:0002446) | 2.69162290 |
| 102 | mRNA stabilization (GO:0048255) | 2.67761284 |
| 103 | RNA stabilization (GO:0043489) | 2.67761284 |
| 104 | IMP metabolic process (GO:0046040) | 2.67526136 |
| 105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.67140682 |
| 106 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.65339646 |
| 107 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.65339646 |
| 108 | leukocyte degranulation (GO:0043299) | 2.65045560 |
| 109 | tetrahydrofolate metabolic process (GO:0046653) | 2.62646019 |
| 110 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60619217 |
| 111 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.59263487 |
| 112 | regulation of necrotic cell death (GO:0010939) | 2.59038725 |
| 113 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.59025602 |
| 114 | negative regulation of interleukin-6 production (GO:0032715) | 2.58719373 |
| 115 | regulation of RNA export from nucleus (GO:0046831) | 2.57862846 |
| 116 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57621482 |
| 117 | formation of translation preinitiation complex (GO:0001731) | 2.57620072 |
| 118 | regulation of spindle organization (GO:0090224) | 2.55947357 |
| 119 | germinal center formation (GO:0002467) | 2.55061623 |
| 120 | pinocytosis (GO:0006907) | 2.54309796 |
| 121 | chromosome condensation (GO:0030261) | 2.53478727 |
| 122 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53413229 |
| 123 | mitotic chromosome condensation (GO:0007076) | 2.51898414 |
| 124 | defense response to protozoan (GO:0042832) | 2.51734556 |
| 125 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.50452800 |
| 126 | nuclear envelope organization (GO:0006998) | 2.49709693 |
| 127 | folic acid metabolic process (GO:0046655) | 2.48924985 |
| 128 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.41751075 |
| 129 | mitotic sister chromatid segregation (GO:0000070) | 2.41521450 |
| 130 | DNA strand elongation (GO:0022616) | 2.40002338 |
| 131 | translesion synthesis (GO:0019985) | 2.39339053 |
| 132 | DNA conformation change (GO:0071103) | 2.38892251 |
| 133 | sister chromatid segregation (GO:0000819) | 2.38282091 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.38263462 |
| 135 | glycine metabolic process (GO:0006544) | 2.35626331 |
| 136 | maternal placenta development (GO:0001893) | 2.34327734 |
| 137 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.34293310 |
| 138 | regulation of mitotic spindle organization (GO:0060236) | 2.33977732 |
| 139 | gene silencing by RNA (GO:0031047) | 2.31332363 |
| 140 | response to UV-C (GO:0010225) | 2.31291737 |
| 141 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.30428394 |
| 142 | DNA packaging (GO:0006323) | 2.30120326 |
| 143 | DNA replication initiation (GO:0006270) | 2.29109159 |
| 144 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.28610991 |
| 145 | NLS-bearing protein import into nucleus (GO:0006607) | 2.27209992 |
| 146 | mitotic metaphase plate congression (GO:0007080) | 2.27163367 |
| 147 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.24812927 |
| 148 | positive regulation of histone deacetylation (GO:0031065) | 2.23650687 |
| 149 | COPI coating of Golgi vesicle (GO:0048205) | 2.22286701 |
| 150 | Golgi transport vesicle coating (GO:0048200) | 2.22286701 |
| 151 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.22173481 |
| 152 | T cell apoptotic process (GO:0070231) | 2.20545002 |
| 153 | regulation of histone H3-K9 methylation (GO:0051570) | 2.19817375 |
| 154 | negative regulation of histone methylation (GO:0031061) | 2.19657461 |
| 155 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.19159989 |
| 156 | histone-serine phosphorylation (GO:0035404) | 2.17629840 |
| 157 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.17543519 |
| 158 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.17127400 |
| 159 | gene silencing (GO:0016458) | 2.16997408 |
| 160 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.13925827 |
| 161 | endothelial tube morphogenesis (GO:0061154) | 2.13639391 |
| 162 | morphogenesis of an endothelium (GO:0003159) | 2.13639391 |
| 163 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.13603099 |
| 164 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.13603099 |
| 165 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.13129308 |
| 166 | folic acid-containing compound metabolic process (GO:0006760) | 2.12803310 |
| 167 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.12635360 |
| 168 | cellular hyperosmotic response (GO:0071474) | 2.10280991 |
| 169 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.10022128 |
| 170 | hippo signaling (GO:0035329) | 2.08109846 |
| 171 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.08012448 |
| 172 | regulation of cholesterol homeostasis (GO:2000188) | 2.07443619 |
| 173 | protein localization to chromosome (GO:0034502) | 2.06507012 |
| 174 | regulation of mRNA stability (GO:0043488) | 2.06400843 |
| 175 | positive regulation of nuclease activity (GO:0032075) | 2.06110952 |
| 176 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.05602348 |
| 177 | mitotic recombination (GO:0006312) | 2.05503542 |
| 178 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.05121612 |
| 179 | trophectodermal cell differentiation (GO:0001829) | 2.04258274 |
| 180 | regulation of hippo signaling (GO:0035330) | 2.03310228 |
| 181 | telomere maintenance via recombination (GO:0000722) | 2.02982846 |
| 182 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.02889521 |
| 183 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.02652866 |
| 184 | DNA replication checkpoint (GO:0000076) | 2.02418374 |
| 185 | positive regulation of chromosome segregation (GO:0051984) | 2.02091055 |
| 186 | apoptotic cell clearance (GO:0043277) | 2.01463863 |
| 187 | hepatocyte apoptotic process (GO:0097284) | 2.01183037 |
| 188 | chromatin assembly (GO:0031497) | 2.01182949 |
| 189 | regulation of gamma-delta T cell activation (GO:0046643) | 2.00563274 |
| 190 | regulation of RNA stability (GO:0043487) | 2.00510454 |
| 191 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 1.99973539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.32894613 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.60751884 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.51921397 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.83845017 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.60272584 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.57586766 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.46675763 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22156322 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.07174239 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.06344595 |
| 11 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.98523702 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97789658 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96581890 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.92915599 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.92562920 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89412610 |
| 17 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87462790 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82696686 |
| 19 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.82019980 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81911713 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.79207562 |
| 22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.78030525 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77781844 |
| 24 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76452858 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64951336 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.64401761 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63474580 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62293277 |
| 29 | GATA1_19941826_ChIP-Seq_K562_Human | 1.60162527 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59728713 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57487735 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57354583 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55642175 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55065253 |
| 35 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54967520 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.51844365 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51162655 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47687699 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.47423190 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.46274779 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.45857480 |
| 42 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45576564 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44604617 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42588070 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.39791256 |
| 46 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38514387 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38436174 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38353754 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38139529 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37566100 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36233920 |
| 52 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35682883 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.35179504 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34647787 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33819845 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33709522 |
| 57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32994356 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32252426 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30914248 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30779397 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.29942928 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29635138 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29473270 |
| 64 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28160315 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26987159 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26978401 |
| 67 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24824227 |
| 68 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24241850 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23602007 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23598148 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23394338 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.23357216 |
| 73 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23096211 |
| 74 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21913556 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21630187 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21515772 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19894697 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19668741 |
| 79 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19044446 |
| 80 | MYB_26560356_Chip-Seq_TH2_Human | 1.19008668 |
| 81 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18717087 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18367560 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18291967 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18205517 |
| 85 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.17893236 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17037081 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15960472 |
| 88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15870553 |
| 89 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.15663587 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15469391 |
| 91 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14369547 |
| 92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.14214998 |
| 93 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.13259825 |
| 94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12803651 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12190054 |
| 96 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10582194 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09747771 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09672234 |
| 99 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09581860 |
| 100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09186877 |
| 101 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08844039 |
| 102 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08821932 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.08183698 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07781200 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07334704 |
| 106 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06587073 |
| 107 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06109496 |
| 108 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.05454963 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05376592 |
| 110 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05309934 |
| 111 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.05207461 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04927239 |
| 113 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04592042 |
| 114 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04553806 |
| 115 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03057186 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02917835 |
| 117 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02436579 |
| 118 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99817630 |
| 119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99263651 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99189423 |
| 121 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.98839966 |
| 122 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98031176 |
| 123 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97657052 |
| 124 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97316277 |
| 125 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97115898 |
| 126 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97045016 |
| 127 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96678030 |
| 128 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.96469713 |
| 129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95396081 |
| 130 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95075821 |
| 131 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95064469 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94447307 |
| 133 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.94414409 |
| 134 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.93800264 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93647789 |
| 136 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93326925 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92942002 |
| 138 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.92547833 |
| 139 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91572001 |
| 140 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90916649 |
| 141 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90739538 |
| 142 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.90003354 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89666975 |
| 144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89069624 |
| 145 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89022680 |
| 146 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88594645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.17596183 |
| 2 | MP0008260_abnormal_autophagy | 3.00581824 |
| 3 | MP0003724_increased_susceptibility_to | 2.89045470 |
| 4 | MP0005451_abnormal_body_composition | 2.56976654 |
| 5 | MP0010352_gastrointestinal_tract_polyps | 2.53399158 |
| 6 | MP0002419_abnormal_innate_immunity | 2.50568663 |
| 7 | MP0005025_abnormal_response_to | 2.49329730 |
| 8 | MP0005671_abnormal_response_to | 2.35908394 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.33266489 |
| 10 | MP0003656_abnormal_erythrocyte_physiolo | 2.28977325 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.26619336 |
| 12 | MP0005387_immune_system_phenotype | 2.23677490 |
| 13 | MP0001790_abnormal_immune_system | 2.23677490 |
| 14 | MP0009785_altered_susceptibility_to | 2.21221591 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.20202412 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.18368567 |
| 17 | MP0001819_abnormal_immune_cell | 2.17703212 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.16299463 |
| 19 | MP0002723_abnormal_immune_serum | 2.15894022 |
| 20 | MP0003566_abnormal_cell_adhesion | 1.98946405 |
| 21 | MP0010094_abnormal_chromosome_stability | 1.98171608 |
| 22 | MP0010307_abnormal_tumor_latency | 1.96634911 |
| 23 | MP0008057_abnormal_DNA_replication | 1.92458663 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.86820589 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.86317466 |
| 26 | MP0003077_abnormal_cell_cycle | 1.84390053 |
| 27 | MP0002396_abnormal_hematopoietic_system | 1.77364296 |
| 28 | MP0006082_CNS_inflammation | 1.76173344 |
| 29 | MP0008007_abnormal_cellular_replicative | 1.69964509 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.67327553 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.65188795 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.65084121 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.63718924 |
| 34 | MP0009840_abnormal_foam_cell | 1.61720319 |
| 35 | MP0002132_abnormal_respiratory_system | 1.59968409 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.59135577 |
| 37 | MP0004957_abnormal_blastocyst_morpholog | 1.57641737 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.57576083 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.57576083 |
| 40 | MP0009278_abnormal_bone_marrow | 1.53602132 |
| 41 | MP0001730_embryonic_growth_arrest | 1.53564721 |
| 42 | MP0005023_abnormal_wound_healing | 1.50098548 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.49228329 |
| 44 | MP0003866_abnormal_defecation | 1.49191766 |
| 45 | MP0004381_abnormal_hair_follicle | 1.44060429 |
| 46 | MP0000350_abnormal_cell_proliferation | 1.39813829 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.39025418 |
| 48 | MP0000490_abnormal_crypts_of | 1.34218038 |
| 49 | MP0004947_skin_inflammation | 1.33194568 |
| 50 | MP0003984_embryonic_growth_retardation | 1.32347982 |
| 51 | MP0008469_abnormal_protein_level | 1.32059891 |
| 52 | MP0003828_pulmonary_edema | 1.30299276 |
| 53 | MP0005360_urolithiasis | 1.30163559 |
| 54 | MP0002088_abnormal_embryonic_growth/wei | 1.29077436 |
| 55 | MP0005380_embryogenesis_phenotype | 1.27989813 |
| 56 | MP0001672_abnormal_embryogenesis/_devel | 1.27989813 |
| 57 | MP0005310_abnormal_salivary_gland | 1.27989101 |
| 58 | MP0003436_decreased_susceptibility_to | 1.24880338 |
| 59 | MP0001873_stomach_inflammation | 1.24352632 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.21546392 |
| 61 | MP0006054_spinal_hemorrhage | 1.20190348 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.20031518 |
| 63 | MP0005365_abnormal_bile_salt | 1.19291792 |
| 64 | MP0008058_abnormal_DNA_repair | 1.17894492 |
| 65 | MP0005275_abnormal_skin_tensile | 1.17828036 |
| 66 | MP0003303_peritoneal_inflammation | 1.16974162 |
| 67 | MP0009764_decreased_sensitivity_to | 1.16805326 |
| 68 | MP0001849_ear_inflammation | 1.13267814 |
| 69 | MP0002086_abnormal_extraembryonic_tissu | 1.12522781 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.12409243 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.10501720 |
| 72 | MP0004197_abnormal_fetal_growth/weight/ | 1.09601360 |
| 73 | MP0000685_abnormal_immune_system | 1.09347821 |
| 74 | MP0000733_abnormal_muscle_development | 1.07569950 |
| 75 | MP0003252_abnormal_bile_duct | 1.07111906 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.06274682 |
| 77 | MP0001915_intracranial_hemorrhage | 1.05654787 |
| 78 | MP0001853_heart_inflammation | 1.04922087 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.04530110 |
| 80 | MP0001958_emphysema | 1.03337310 |
| 81 | MP0002080_prenatal_lethality | 1.03108621 |
| 82 | MP0001697_abnormal_embryo_size | 1.03007810 |
| 83 | MP0002019_abnormal_tumor_incidence | 1.00858177 |
| 84 | MP0002060_abnormal_skin_morphology | 0.99372700 |
| 85 | MP0004264_abnormal_extraembryonic_tissu | 0.97590735 |
| 86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97528425 |
| 87 | MP0002398_abnormal_bone_marrow | 0.95818349 |
| 88 | MP0003763_abnormal_thymus_physiology | 0.95665265 |
| 89 | MP0004883_abnormal_blood_vessel | 0.95438559 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.95387289 |
| 91 | MP0000858_altered_metastatic_potential | 0.95153869 |
| 92 | MP0002722_abnormal_immune_system | 0.95029824 |
| 93 | MP0010155_abnormal_intestine_physiology | 0.93826522 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.93589390 |
| 95 | MP0003075_altered_response_to | 0.93213927 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.92910128 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.92834054 |
| 98 | MP0000609_abnormal_liver_physiology | 0.92404773 |
| 99 | MP0001851_eye_inflammation | 0.92268872 |
| 100 | MP0000313_abnormal_cell_death | 0.91977769 |
| 101 | MP0009053_abnormal_anal_canal | 0.91923880 |
| 102 | MP0000598_abnormal_liver_morphology | 0.91917939 |
| 103 | MP0010368_abnormal_lymphatic_system | 0.91014875 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.89973095 |
| 105 | MP0002405_respiratory_system_inflammati | 0.88796773 |
| 106 | MP0003091_abnormal_cell_migration | 0.88344342 |
| 107 | MP0003115_abnormal_respiratory_system | 0.87819106 |
| 108 | MP0000703_abnormal_thymus_morphology | 0.87640463 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.87136697 |
| 110 | MP0003279_aneurysm | 0.86675667 |
| 111 | MP0005464_abnormal_platelet_physiology | 0.85692530 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.85274324 |
| 113 | MP0005164_abnormal_response_to | 0.84083538 |
| 114 | MP0009763_increased_sensitivity_to | 0.83726977 |
| 115 | MP0003448_altered_tumor_morphology | 0.83483732 |
| 116 | MP0001243_abnormal_dermal_layer | 0.83367003 |
| 117 | MP0008961_abnormal_basal_metabolism | 0.83073620 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.82882844 |
| 119 | MP0010630_abnormal_cardiac_muscle | 0.82815620 |
| 120 | MP0000604_amyloidosis | 0.82229657 |
| 121 | MP0003806_abnormal_nucleotide_metabolis | 0.81904737 |
| 122 | MP0001800_abnormal_humoral_immune | 0.81812229 |
| 123 | MP0005621_abnormal_cell_physiology | 0.80941346 |
| 124 | MP0001663_abnormal_digestive_system | 0.80433086 |
| 125 | MP0002085_abnormal_embryonic_tissue | 0.80360795 |
| 126 | MP0001835_abnormal_antigen_presentation | 0.79694992 |
| 127 | MP0003786_premature_aging | 0.79663905 |
| 128 | MP0010030_abnormal_orbit_morphology | 0.78976077 |
| 129 | MP0002084_abnormal_developmental_patter | 0.78539341 |
| 130 | MP0002452_abnormal_antigen_presenting | 0.77737295 |
| 131 | MP0002429_abnormal_blood_cell | 0.77715294 |
| 132 | MP0008932_abnormal_embryonic_tissue | 0.77529737 |
| 133 | MP0005085_abnormal_gallbladder_physiolo | 0.77447510 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.75802988 |
| 135 | MP0004858_abnormal_nervous_system | 0.73797275 |
| 136 | MP0005058_abnormal_lysosome_morphology | 0.72860620 |
| 137 | MP0000477_abnormal_intestine_morphology | 0.72815358 |
| 138 | MP0005083_abnormal_biliary_tract | 0.72251825 |
| 139 | MP0005390_skeleton_phenotype | 0.71950309 |
| 140 | MP0009672_abnormal_birth_weight | 0.71826174 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.71622514 |
| 142 | MP0000716_abnormal_immune_system | 0.71080054 |
| 143 | MP0009931_abnormal_skin_appearance | 0.70998919 |
| 144 | MP0005257_abnormal_intraocular_pressure | 0.70764528 |
| 145 | MP0002933_joint_inflammation | 0.69295266 |
| 146 | MP0005166_decreased_susceptibility_to | 0.68334745 |
| 147 | MP0003795_abnormal_bone_structure | 0.67799191 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67597392 |
| 149 | MP0005501_abnormal_skin_physiology | 0.64712618 |
| 150 | MP0002006_tumorigenesis | 0.64484635 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.64343908 |
| 152 | MP0000343_altered_response_to | 0.63587766 |
| 153 | MP0000249_abnormal_blood_vessel | 0.62790948 |
| 154 | MP0002970_abnormal_white_adipose | 0.60954417 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60389019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 5.60170879 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.82230062 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.80353354 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.15903976 |
| 5 | Myositis (HP:0100614) | 4.11221022 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.10705578 |
| 7 | Hypochromic anemia (HP:0001931) | 4.06233215 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.94709987 |
| 9 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.69753270 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.60452262 |
| 11 | Obstructive lung disease (HP:0006536) | 3.60452262 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.58547875 |
| 13 | Orchitis (HP:0100796) | 3.45994482 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.44008992 |
| 15 | Stomatitis (HP:0010280) | 3.38167870 |
| 16 | Urticaria (HP:0001025) | 3.33801358 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.27996897 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.25451981 |
| 19 | Increased IgE level (HP:0003212) | 3.19626512 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.19348982 |
| 21 | Meningitis (HP:0001287) | 3.18522252 |
| 22 | Microcytic anemia (HP:0001935) | 3.16866881 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.10556434 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.10311085 |
| 25 | Recurrent skin infections (HP:0001581) | 3.09949812 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 3.04757382 |
| 27 | Protrusio acetabuli (HP:0003179) | 3.01612624 |
| 28 | Cellulitis (HP:0100658) | 2.99815991 |
| 29 | Inflammation of the large intestine (HP:0002037) | 2.94991157 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 2.89996255 |
| 31 | Optic neuritis (HP:0100653) | 2.89996255 |
| 32 | Gingivitis (HP:0000230) | 2.89932324 |
| 33 | Epistaxis (HP:0000421) | 2.80311997 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75827901 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75827901 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.71147440 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.71147440 |
| 38 | Abnormality of glycolipid metabolism (HP:0010969) | 2.71147440 |
| 39 | Vasculitis (HP:0002633) | 2.67613330 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.64707842 |
| 41 | Encephalitis (HP:0002383) | 2.63670210 |
| 42 | T lymphocytopenia (HP:0005403) | 2.63530471 |
| 43 | Abnormality of the fingertips (HP:0001211) | 2.60510660 |
| 44 | Premature rupture of membranes (HP:0001788) | 2.58122786 |
| 45 | Colitis (HP:0002583) | 2.56678884 |
| 46 | Chest pain (HP:0100749) | 2.55246198 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.54486010 |
| 48 | Selective tooth agenesis (HP:0001592) | 2.52402825 |
| 49 | Increased serum ferritin (HP:0003281) | 2.51734843 |
| 50 | High pitched voice (HP:0001620) | 2.49382888 |
| 51 | Ulnar bowing (HP:0003031) | 2.44822928 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.42267675 |
| 53 | Slow saccadic eye movements (HP:0000514) | 2.39986331 |
| 54 | Increased connective tissue (HP:0009025) | 2.39073713 |
| 55 | Degeneration of anterior horn cells (HP:0002398) | 2.38514187 |
| 56 | Abnormality of the anterior horn cell (HP:0006802) | 2.38514187 |
| 57 | Hyperacusis (HP:0010780) | 2.38315337 |
| 58 | Granulocytopenia (HP:0001913) | 2.37671395 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.36543272 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.35271221 |
| 61 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35271221 |
| 62 | Abnormality of T cells (HP:0002843) | 2.33573047 |
| 63 | Increased cerebral lipofuscin (HP:0011813) | 2.30750195 |
| 64 | Purpura (HP:0000979) | 2.30218309 |
| 65 | Cholelithiasis (HP:0001081) | 2.26146186 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 2.25894495 |
| 67 | Amyloidosis (HP:0011034) | 2.23179087 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.22542543 |
| 69 | Polycythemia (HP:0001901) | 2.22289593 |
| 70 | Thin bony cortex (HP:0002753) | 2.19517547 |
| 71 | Leukocytosis (HP:0001974) | 2.16944961 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.16641388 |
| 73 | Episodic fever (HP:0001954) | 2.13992052 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.13760223 |
| 75 | Increased IgM level (HP:0003496) | 2.11668641 |
| 76 | Shallow orbits (HP:0000586) | 2.11065591 |
| 77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11031388 |
| 78 | Hypertriglyceridemia (HP:0002155) | 2.10581740 |
| 79 | Increased density of long bones (HP:0006392) | 2.10459544 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.10455735 |
| 81 | Osteomyelitis (HP:0002754) | 2.08100932 |
| 82 | Cervical subluxation (HP:0003308) | 2.08066589 |
| 83 | Thrombocytosis (HP:0001894) | 2.08057107 |
| 84 | Nasal polyposis (HP:0100582) | 2.07975054 |
| 85 | Loss of speech (HP:0002371) | 2.07685712 |
| 86 | Lymphopenia (HP:0001888) | 2.05320414 |
| 87 | Hypertensive crisis (HP:0100735) | 2.04944234 |
| 88 | Increased mean platelet volume (HP:0011877) | 2.03989730 |
| 89 | Aortic aneurysm (HP:0004942) | 2.03795975 |
| 90 | Aneurysm (HP:0002617) | 2.03564230 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.02549619 |
| 92 | Abnormality of T cell physiology (HP:0011840) | 2.01140626 |
| 93 | Deep venous thrombosis (HP:0002625) | 2.00810237 |
| 94 | Verrucae (HP:0200043) | 1.99913922 |
| 95 | Papilloma (HP:0012740) | 1.99913922 |
| 96 | Autoimmune hemolytic anemia (HP:0001890) | 1.98857997 |
| 97 | Abnormal platelet volume (HP:0011876) | 1.98275281 |
| 98 | Myocardial infarction (HP:0001658) | 1.97651100 |
| 99 | Peritonitis (HP:0002586) | 1.97222347 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 1.96362079 |
| 101 | Hypergammaglobulinemia (HP:0010702) | 1.96230388 |
| 102 | Arterial thrombosis (HP:0004420) | 1.95783430 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95180890 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95180890 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95180890 |
| 106 | Recurrent viral infections (HP:0004429) | 1.95165054 |
| 107 | Ragged-red muscle fibers (HP:0003200) | 1.94695274 |
| 108 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93558380 |
| 109 | Difficulty climbing stairs (HP:0003551) | 1.92864002 |
| 110 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.92070197 |
| 111 | Skin ulcer (HP:0200042) | 1.92063907 |
| 112 | Hepatosplenomegaly (HP:0001433) | 1.91759162 |
| 113 | Hemoptysis (HP:0002105) | 1.91547817 |
| 114 | Toxemia of pregnancy (HP:0100603) | 1.91268516 |
| 115 | Abnormal gallbladder morphology (HP:0012437) | 1.91000190 |
| 116 | Keratoconjunctivitis (HP:0001096) | 1.90803237 |
| 117 | Eczematoid dermatitis (HP:0000976) | 1.89612202 |
| 118 | Pustule (HP:0200039) | 1.89088138 |
| 119 | Genu recurvatum (HP:0002816) | 1.86742974 |
| 120 | Upper limb amyotrophy (HP:0009129) | 1.86512965 |
| 121 | Distal upper limb amyotrophy (HP:0007149) | 1.86512965 |
| 122 | Sepsis (HP:0100806) | 1.86290716 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.86169459 |
| 124 | Cholecystitis (HP:0001082) | 1.86031078 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 1.86031078 |
| 126 | Ankle contracture (HP:0006466) | 1.85776894 |
| 127 | Hand muscle atrophy (HP:0009130) | 1.85005564 |
| 128 | Anorexia (HP:0002039) | 1.84759038 |
| 129 | Abnormality of the peritoneum (HP:0002585) | 1.84279720 |
| 130 | Prominent nose (HP:0000448) | 1.83815458 |
| 131 | Long toe (HP:0010511) | 1.83746658 |
| 132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83707774 |
| 133 | Ependymoma (HP:0002888) | 1.83339921 |
| 134 | Abnormal hemoglobin (HP:0011902) | 1.82912679 |
| 135 | Increased nuchal translucency (HP:0010880) | 1.82667615 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.82587406 |
| 137 | Urethral obstruction (HP:0000796) | 1.81184720 |
| 138 | Broad palm (HP:0001169) | 1.78950985 |
| 139 | Reticulocytosis (HP:0001923) | 1.76438722 |
| 140 | Dilatation of the ascending aorta (HP:0005111) | 1.74914886 |
| 141 | Renovascular hypertension (HP:0100817) | 1.74333409 |
| 142 | Subacute progressive viral hepatitis (HP:0006572) | 1.73015187 |
| 143 | Impulsivity (HP:0100710) | 1.72816830 |
| 144 | Esophageal varix (HP:0002040) | 1.72384371 |
| 145 | Lip pit (HP:0100267) | 1.72264321 |
| 146 | Nonimmune hydrops fetalis (HP:0001790) | 1.70205326 |
| 147 | Renal duplication (HP:0000075) | 1.69551794 |
| 148 | Long eyelashes (HP:0000527) | 1.68751949 |
| 149 | Bicuspid aortic valve (HP:0001647) | 1.68489982 |
| 150 | Bladder diverticulum (HP:0000015) | 1.63307059 |
| 151 | Disproportionate tall stature (HP:0001519) | 1.62642034 |
| 152 | Mitral valve prolapse (HP:0001634) | 1.60250777 |
| 153 | Short nail (HP:0001799) | 1.58784880 |
| 154 | Bowel diverticulosis (HP:0005222) | 1.57644869 |
| 155 | Bowed forearm bones (HP:0003956) | 1.56309322 |
| 156 | Bowing of the arm (HP:0006488) | 1.56309322 |
| 157 | Hematochezia (HP:0002573) | 1.55846446 |
| 158 | Flat acetabular roof (HP:0003180) | 1.55711149 |
| 159 | Periodontitis (HP:0000704) | 1.55674614 |
| 160 | Spastic diplegia (HP:0001264) | 1.55378800 |
| 161 | Radial bowing (HP:0002986) | 1.55246376 |
| 162 | Deviation of the thumb (HP:0009603) | 1.54705733 |
| 163 | Hallux valgus (HP:0001822) | 1.53176499 |
| 164 | Abnormality of the acetabulum (HP:0003170) | 1.52695778 |
| 165 | Right ventricular cardiomyopathy (HP:0011663) | 1.52523072 |
| 166 | Abnormality of the lower motor neuron (HP:0002366) | 1.52381644 |
| 167 | Ulnar deviation of the wrist (HP:0003049) | 1.52045837 |
| 168 | Heterotopia (HP:0002282) | 1.49871715 |
| 169 | Deviation of the hallux (HP:0010051) | 1.49635789 |
| 170 | Gingival bleeding (HP:0000225) | 1.49142612 |
| 171 | Conjunctival telangiectasia (HP:0000524) | 1.48630911 |
| 172 | Squamous cell carcinoma (HP:0002860) | 1.47956397 |
| 173 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.47871514 |
| 174 | Gastrointestinal carcinoma (HP:0002672) | 1.47249280 |
| 175 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.47249280 |
| 176 | Multiple enchondromatosis (HP:0005701) | 1.47238498 |
| 177 | Abnormality of the gastric mucosa (HP:0004295) | 1.45358358 |
| 178 | Biconcave vertebral bodies (HP:0004586) | 1.45355069 |
| 179 | Abnormality of the calcaneus (HP:0008364) | 1.44492557 |
| 180 | Slender long bone (HP:0003100) | 1.43095973 |
| 181 | Distal lower limb amyotrophy (HP:0008944) | 1.42614733 |
| 182 | Abnormal platelet function (HP:0011869) | 1.40683466 |
| 183 | Impaired platelet aggregation (HP:0003540) | 1.40683466 |
| 184 | Skin tags (HP:0010609) | 1.40063501 |
| 185 | Proximal placement of thumb (HP:0009623) | 1.39895392 |
| 186 | Elfin facies (HP:0004428) | 1.39661721 |
| 187 | Metaphyseal cupping (HP:0003021) | 1.39427461 |
| 188 | Persistence of primary teeth (HP:0006335) | 1.38139298 |
| 189 | Petechiae (HP:0000967) | 1.38119868 |
| 190 | Cutaneous melanoma (HP:0012056) | 1.37713026 |
| 191 | Entropion (HP:0000621) | 1.37623300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.84247292 |
| 2 | PKN2 | 3.13246360 |
| 3 | RIPK4 | 3.12033675 |
| 4 | CDK12 | 3.02269068 |
| 5 | ERN1 | 2.78779096 |
| 6 | EEF2K | 2.52503421 |
| 7 | NEK2 | 2.37014661 |
| 8 | MAP3K10 | 2.29425620 |
| 9 | IRAK4 | 2.26922505 |
| 10 | MAP4K1 | 2.25592722 |
| 11 | PRPF4B | 2.09658123 |
| 12 | STK3 | 1.92203224 |
| 13 | STK10 | 1.86853855 |
| 14 | CDC7 | 1.85554283 |
| 15 | TNK2 | 1.85020909 |
| 16 | TTN | 1.84800669 |
| 17 | PTK6 | 1.75680750 |
| 18 | FES | 1.70462531 |
| 19 | IKBKE | 1.65163376 |
| 20 | SMG1 | 1.64700894 |
| 21 | FGR | 1.58127871 |
| 22 | TTK | 1.56683287 |
| 23 | LRRK2 | 1.53666977 |
| 24 | MAP2K3 | 1.50484512 |
| 25 | TESK1 | 1.46251053 |
| 26 | TXK | 1.45174795 |
| 27 | RPS6KA4 | 1.43891664 |
| 28 | FGFR4 | 1.43559401 |
| 29 | MAP3K13 | 1.41772312 |
| 30 | BUB1 | 1.40833541 |
| 31 | ZAP70 | 1.38667124 |
| 32 | SCYL2 | 1.38447325 |
| 33 | SIK3 | 1.37079108 |
| 34 | PAK4 | 1.36746277 |
| 35 | SYK | 1.35597628 |
| 36 | MAP3K1 | 1.34891863 |
| 37 | CDK4 | 1.34730302 |
| 38 | HCK | 1.30035958 |
| 39 | MTOR | 1.27760424 |
| 40 | NEK9 | 1.25793267 |
| 41 | SIK1 | 1.25367636 |
| 42 | ICK | 1.21563152 |
| 43 | MAP3K8 | 1.20538022 |
| 44 | STK4 | 1.20318724 |
| 45 | TAOK2 | 1.20159356 |
| 46 | WEE1 | 1.19958147 |
| 47 | CDK6 | 1.17274562 |
| 48 | JAK3 | 1.16240872 |
| 49 | PRKD2 | 1.14199666 |
| 50 | TBK1 | 1.12494505 |
| 51 | TYK2 | 1.10990341 |
| 52 | TESK2 | 1.09025740 |
| 53 | PASK | 1.07963896 |
| 54 | RPS6KB2 | 1.00648269 |
| 55 | MARK2 | 1.00147562 |
| 56 | LYN | 0.99610062 |
| 57 | ATR | 0.97185998 |
| 58 | IKBKB | 0.97156773 |
| 59 | LATS1 | 0.97110924 |
| 60 | PIM2 | 0.97048448 |
| 61 | PIM1 | 0.96741012 |
| 62 | MARK3 | 0.96289974 |
| 63 | PTK2B | 0.93613703 |
| 64 | KSR2 | 0.92193581 |
| 65 | EPHA2 | 0.91751925 |
| 66 | PAK2 | 0.91042594 |
| 67 | LCK | 0.90996210 |
| 68 | PDK4 | 0.89149965 |
| 69 | PDK3 | 0.89149965 |
| 70 | ALK | 0.88516037 |
| 71 | EIF2AK1 | 0.86750554 |
| 72 | RIPK1 | 0.86550322 |
| 73 | PDGFRA | 0.86288533 |
| 74 | PLK1 | 0.86145500 |
| 75 | CHEK1 | 0.86062053 |
| 76 | AURKB | 0.85824520 |
| 77 | NEK1 | 0.85656337 |
| 78 | CHUK | 0.84828500 |
| 79 | CDK7 | 0.83943436 |
| 80 | BRD4 | 0.82300076 |
| 81 | BMX | 0.80234022 |
| 82 | CDC42BPA | 0.80189278 |
| 83 | FLT3 | 0.79213670 |
| 84 | SIK2 | 0.77744239 |
| 85 | CLK1 | 0.75284046 |
| 86 | EPHB1 | 0.74016823 |
| 87 | TSSK6 | 0.70904862 |
| 88 | TGFBR2 | 0.70177925 |
| 89 | TAOK1 | 0.68715830 |
| 90 | MAP3K3 | 0.68048113 |
| 91 | FGFR1 | 0.66496520 |
| 92 | MATK | 0.66267955 |
| 93 | PDK1 | 0.66167584 |
| 94 | HIPK2 | 0.65633177 |
| 95 | PDPK1 | 0.65284076 |
| 96 | NME2 | 0.64538675 |
| 97 | TGFBR1 | 0.63928185 |
| 98 | KIT | 0.63658734 |
| 99 | CSF1R | 0.62598974 |
| 100 | DYRK1B | 0.62312319 |
| 101 | PIK3CG | 0.62031061 |
| 102 | BTK | 0.61789123 |
| 103 | PTK2 | 0.60891774 |
| 104 | MAP3K7 | 0.59715251 |
| 105 | DDR2 | 0.57807876 |
| 106 | JAK1 | 0.57760059 |
| 107 | MAPKAPK2 | 0.57372769 |
| 108 | BRSK2 | 0.56084395 |
| 109 | TRPM7 | 0.55436935 |
| 110 | FGFR3 | 0.55363947 |
| 111 | MAP3K11 | 0.54786019 |
| 112 | PDGFRB | 0.53538431 |
| 113 | MAPKAPK3 | 0.53187349 |
| 114 | CDK2 | 0.52584734 |
| 115 | IRAK1 | 0.51857164 |
| 116 | CSK | 0.51066570 |
| 117 | STK38 | 0.51040690 |
| 118 | MAPK11 | 0.51039628 |
| 119 | BCKDK | 0.50737648 |
| 120 | TAOK3 | 0.50329366 |
| 121 | MAP3K6 | 0.50216664 |
| 122 | IRAK3 | 0.49630393 |
| 123 | MAP2K2 | 0.49234001 |
| 124 | KDR | 0.49156283 |
| 125 | MAP3K14 | 0.48855848 |
| 126 | RPS6KC1 | 0.48744979 |
| 127 | RPS6KL1 | 0.48744979 |
| 128 | ATM | 0.48624693 |
| 129 | DYRK3 | 0.48622687 |
| 130 | BLK | 0.48611869 |
| 131 | ITK | 0.48307908 |
| 132 | GRK6 | 0.47493330 |
| 133 | STK24 | 0.47284513 |
| 134 | CHEK2 | 0.47239081 |
| 135 | JAK2 | 0.46755012 |
| 136 | MAP3K5 | 0.46518047 |
| 137 | RAF1 | 0.45651497 |
| 138 | MAPK12 | 0.45596129 |
| 139 | PAK1 | 0.44686288 |
| 140 | IRAK2 | 0.44598936 |
| 141 | CAMK1D | 0.43507506 |
| 142 | MAP3K2 | 0.39616807 |
| 143 | RPS6KA6 | 0.36872805 |
| 144 | ARAF | 0.35006041 |
| 145 | TEC | 0.34423675 |
| 146 | YES1 | 0.34007336 |
| 147 | GRK5 | 0.33707580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.53893140 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.51202066 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.37494587 |
| 4 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.24836526 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.04332567 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03095252 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.02597740 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.98077722 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.97156121 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93183950 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.76993702 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.71989249 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.71353801 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.68508127 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 1.64436657 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.62040998 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59611705 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.59522875 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56962452 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.44471717 |
| 21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.43560003 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41645689 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41329360 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40807945 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.40697542 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40376392 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36780787 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36584827 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.33820286 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.32539251 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31043083 |
| 32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.30984299 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28830480 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.26584353 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.26402763 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26176942 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21806490 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20296668 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.18559086 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.16372987 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16208423 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13614264 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.11827044 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10709872 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10244169 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10118249 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07902286 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04789281 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 1.04681893 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.01393193 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.01343132 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00519030 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00220540 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00119399 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99467425 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99212692 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.98981362 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.97480577 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97062426 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96894022 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.96431004 |
| 62 | Measles_Homo sapiens_hsa05162 | 0.96084747 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95940275 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95614464 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.95095775 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94837233 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94164761 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.93312980 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93277790 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.92531188 |
| 71 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.91516431 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90440982 |
| 73 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.87650377 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.87127559 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87070781 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.86983972 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86070838 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85520245 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84040755 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82279526 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82151041 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.81843779 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80872456 |
| 84 | Influenza A_Homo sapiens_hsa05164 | 0.80197961 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79946079 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79549343 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77728466 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.77717985 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76218109 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75665093 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75613901 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74769744 |
| 93 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74536002 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74194879 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.72770414 |
| 96 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71581578 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70813852 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.70514746 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70444469 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70443161 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70421509 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.70299089 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70078747 |
| 104 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68467910 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.68137128 |
| 106 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67722961 |
| 107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67663610 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.67320753 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66065836 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65526407 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65522118 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64758946 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64625884 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64378579 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63937128 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63677223 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62712772 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.62234298 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61275990 |
| 120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60335622 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60254499 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60008806 |
| 123 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59646121 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.59611941 |
| 125 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59194031 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58691894 |
| 127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58369519 |
| 128 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57819284 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57570746 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56512539 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56281752 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56038689 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55487953 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55381546 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55118074 |
| 136 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54903839 |
| 137 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51864998 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51701580 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51556751 |
| 140 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51031454 |
| 141 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50294491 |
| 142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50159750 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49002766 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.48878657 |
| 145 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48693997 |
| 146 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48312432 |
| 147 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.47745748 |
| 148 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47503248 |
| 149 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45161725 |
| 150 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41836994 |
| 151 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41176499 |
| 152 | Prostate cancer_Homo sapiens_hsa05215 | 0.40980433 |
| 153 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39806439 |

